Line Debois Frejlev Nielsen
CEO & Co-founder at MedicQuant ApS- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
MedicQuant ApS
-
Denmark
-
Medical Equipment Manufacturing
-
1 - 100 Employee
-
CEO & Co-founder
-
Aug 2019 - Present
MedicQuant is a startup company with a mission to enable rapid testing for anticoagulants (DOACs) at the point of care to benefit patients. MedicQuant is a startup company with a mission to enable rapid testing for anticoagulants (DOACs) at the point of care to benefit patients.
-
-
-
Aarhus Universitet
-
Denmark
-
Book and Periodical Publishing
-
1 - 100 Employee
-
Postdoctoral Researcher
-
Dec 2018 - Mar 2020
-
-
-
-
PhD student
-
2015 - 2018
During my PhD project I have primarily worked with development of new methods for small molecule detection. I have extensive experience with bioconjugation, synthesis of small drug molecule derivatives and prototype development. I have further developed and implemented a novel assay in a device for point of care testing of small molecule drugs. Title of PhD dissertation: Development of Small Molecule Sensors for Point-of-Care Testing. Submitted December 2018, defended January 2019 Practical experience with: - Organic synthesis of small molecules and drug derivatives - Synthesis of non-natural DNA - Bioconjugation of small molecules to DNA and proteins - Bioconjugation of DNA to proteins - Development of monoclonal antibodies - Various purification and analysis techniques: Gel electrophoresis, HPLC, LC-MS, NMR, FRET, ELISA - Prototype development Show less
-
-
-
BioPorto Diagnostics A/S
-
Denmark
-
Biotechnology Research
-
1 - 100 Employee
-
Visiting Research Scientist
-
Apr 2017 - Jun 2017
Visiting research scientist in the R&D department in Bioporto Diagnostics A/S. During my stay I worked with development of new monoclonal antibodies against small molecules and optimization of protocols for protein-small molecule couplings. Visiting research scientist in the R&D department in Bioporto Diagnostics A/S. During my stay I worked with development of new monoclonal antibodies against small molecules and optimization of protocols for protein-small molecule couplings.
-
-
-
-
Kontorassistent
-
Aug 2009 - Apr 2015
-
-
Education
-
Aarhus Universitet
Doctor of Philosophy (PhD), Chemistry and Nanoscience -
Aarhus Universitet
Master of Science (M.Sc.), Medicinal Chemistry -
University of Sydney
Chemistry -
Aarhus Universitet
Bachelor of Science (B.Sc.), Medicinal Chemistry -
Silkeborg Gymnasium
Chemistry A, Mathematics A, Biology B, Physics B